ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

DVA DaVita Inc

138.01
2.06 (1.52%)
Last Updated: 19:03:49
Delayed by 15 minutes
Share Name Share Symbol Market Type
DaVita Inc NYSE:DVA NYSE Common Stock
  Price Change % Change Share Price High Price Low Price Open Price Shares Traded Last Trade
  2.06 1.52% 138.01 138.88 136.44 136.90 246,375 19:03:49

DaVita Responds to Senate Bill 1156 Veto

01/10/2018 2:40pm

PR Newswire (US)


DaVita (NYSE:DVA)
Historical Stock Chart


From Jul 2019 to Jul 2024

Click Here for more DaVita Charts.

SACRAMENTO, Calif., Oct. 1, 2018 /PRNewswire/ -- DaVita Kidney Care, a division of DaVita Inc. (NYSE: DVA), and a leading provider of kidney care services in the United States, issued the following statement attributable to Javier Rodriguez, CEO for DaVita Kidney Care.

"We are deeply relieved and want to thank Governor Brown for protecting dialysis patients and vetoing SB 1156, a bill that would have significantly hurt dialysis patients throughout that state," said Javier Rodriguez, CEO for DaVita Kidney Care. "This bill was sponsored and pushed by the SEIU and Blue Shield of California and would have harmed thousands of dialysis patients in California by allowing health plans to discriminate against low-income dialysis patients who rely on charitable assistance to pay their insurance premiums."

About DaVita Kidney Care
DaVita Kidney Care is a division of DaVita Inc., a Fortune 500® company, that through its operating divisions provides a variety of health care services to patient populations throughout the United States and abroad. A leading provider of dialysis services in the United States, DaVita Kidney Care treats patients with chronic kidney failure and end stage renal disease. DaVita Kidney Care strives to improve patients' quality of life by innovating clinical care, and by offering integrated treatment plans, personalized care teams and convenient health-management services. As of June 30, 2018, DaVita Kidney Care operated or provided administrative services at 2,580 outpatient dialysis centers located in the United States serving approximately 201,000 patients. The company also operated 253 outpatient dialysis centers located in 10 countries outside the United States. DaVita Kidney Care supports numerous programs dedicated to creating positive, sustainable change in communities around the world. The company's leadership development initiatives and social responsibility efforts have been recognized by Fortune, Modern Healthcare, Newsweek and WorldBlu. For more information, please visit DaVita.com.

Contact Information
Media:
Alicia Patterson
Alicia.Patterson@davita.com
303-876-6982

DaVita Kidney Care (PRNewsfoto/DaVita Kidney Care)

 

Cision View original content to download multimedia:http://www.prnewswire.com/news-releases/davita-responds-to-senate-bill-1156-veto-300721817.html

SOURCE DaVita

Copyright 2018 PR Newswire

1 Year DaVita Chart

1 Year DaVita Chart

1 Month DaVita Chart

1 Month DaVita Chart

Your Recent History

Delayed Upgrade Clock